BACKGROUND: Medical settings such as emergency departments (EDs) present an opportunity to identify and provide services for individuals with substance use problems who might otherwise never receive any form of assessment, referral, or intervention. Although screening, brief intervention, and referral to treatment models have been extensively studied and are considered effective for individuals with alcohol problems presenting in EDs and other medical settings, the efficacy of such interventions has not been established for drug users presenting in EDs. OBJECTIVES: This article describes the design of a NIDA Clinical Trials Network protocol testing the efficacy of an screening, brief intervention, and referral to treatment model in medical EDs, highlighting considerations that are pertinent to the design of other studies targeting substance use behaviors in medical treatment settings. METHODS: The protocol is described, and critical design decisions are discussed. RESULTS: Design challenges included defining treatment conditions, study population, and site characteristics; developing the screening process; choosing the primary outcome; balancing brevity and comprehensiveness of assessment; and selecting the strategy for statistical analysis. CONCLUSION: Many of the issues arising in the design of this study will be relevant to future studies of interventions for addictions in medical settings. SCIENTIFIC SIGNIFICANCE: Optimal trial design is critical to determining how best to integrate substance abuse interventions into medical care.
RCT Entities:
BACKGROUND: Medical settings such as emergency departments (EDs) present an opportunity to identify and provide services for individuals with substance use problems who might otherwise never receive any form of assessment, referral, or intervention. Although screening, brief intervention, and referral to treatment models have been extensively studied and are considered effective for individuals with alcohol problems presenting in EDs and other medical settings, the efficacy of such interventions has not been established for drug users presenting in EDs. OBJECTIVES: This article describes the design of a NIDA Clinical Trials Network protocol testing the efficacy of an screening, brief intervention, and referral to treatment model in medical EDs, highlighting considerations that are pertinent to the design of other studies targeting substance use behaviors in medical treatment settings. METHODS: The protocol is described, and critical design decisions are discussed. RESULTS: Design challenges included defining treatment conditions, study population, and site characteristics; developing the screening process; choosing the primary outcome; balancing brevity and comprehensiveness of assessment; and selecting the strategy for statistical analysis. CONCLUSION: Many of the issues arising in the design of this study will be relevant to future studies of interventions for addictions in medical settings. SCIENTIFIC SIGNIFICANCE: Optimal trial design is critical to determining how best to integrate substance abuse interventions into medical care.
Authors: Felicity Goodyear-Smith; Nicole M Coupe; Bruce Arroll; C Raina Elley; Sean Sullivan; Anne-Thea McGill Journal: Br J Gen Pract Date: 2008-01 Impact factor: 5.386
Authors: Katharine A Bradley; Anna F DeBenedetti; Robert J Volk; Emily C Williams; Danielle Frank; Daniel R Kivlahan Journal: Alcohol Clin Exp Res Date: 2007-04-19 Impact factor: 3.455
Authors: Li-Tzy Wu; Marvin S Swartz; Zunyou Wu; Paolo Mannelli; Chongming Yang; Dan G Blazer Journal: Ann Emerg Med Date: 2012-03-15 Impact factor: 5.721
Authors: Dennis M Donovan; Mary A Hatch-Maillette; Melissa M Phares; Ernest McGarry; K Michelle Peavy; Julie Taborsky Journal: J Subst Abuse Treat Date: 2014-11-05
Authors: Wendy L Macias Konstantopoulos; Jessica A Dreifuss; Katherine A McDermott; Blair Alden Parry; Melissa L Howell; Raul N Mandler; Garrett M Fitzmaurice; Michael P Bogenschutz; Roger D Weiss Journal: Ann Emerg Med Date: 2014-07-03 Impact factor: 5.721
Authors: Michael P Bogenschutz; Dennis M Donovan; Raul N Mandler; Harold I Perl; Alyssa A Forcehimes; Cameron Crandall; Robert Lindblad; Neal L Oden; Gaurav Sharma; Lisa Metsch; Michael S Lyons; Ryan McCormack; Wendy Macias-Konstantopoulos; Antoine Douaihy Journal: JAMA Intern Med Date: 2014-11 Impact factor: 21.873
Authors: Pilar M Sanjuan; Samara L Rice; Katie Witkiewitz; Raul N Mandler; Cameron Crandall; Michael P Bogenschutz Journal: Drug Alcohol Depend Date: 2014-02-12 Impact factor: 4.492